You clicked on a page that’s meant for healthcare providers.

This section includes technical information. If you’re a US healthcare provider, click “Continue.” Otherwise, click “Return” to keep reading the main site.

You are now leaving the Humalog.com website

The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Lilly USA, LLC, does not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Lilly USA, LLC. Lilly USA, LLC, is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.

Click "Continue" to proceed or "Cancel" to return to Humalog.com

Indication for Humalog Brand of Insulins and Insulin Lispro Injection

Humalog and Insulin Lispro Injection are used to treat people with diabetes for the control of high blood sugar. Humalog Mix75/25 and Humalog Mix50/50 are used to treat adults with diabetes for the control of high blood sugar.

Important Safety Information for Humalog Brand of Insulins and Insulin Lispro Injection

What is the most important information I should know about Humalog U-100, Humalog U-200, Humalog Mix75/25, Humalog Mix50/50, and Insulin Lispro Injection?

  • Do not share your Humalog U-100, Humalog U-200, Humalog Mix75/25, Humalog Mix50/50, or Insulin Lispro Injection prefilled pen, cartridges, reusable pen compatible with Lilly 3 mL cartridges, needles, or syringes with other people, even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.
  • Do not change the type or amount of insulin you use without talking to your healthcare provider. Changes may make you more likely to experience low or high blood sugar. Changes should be made cautiously under the supervision of your healthcare provider.
  • Check your blood sugar levels as your healthcare provider instructs.
  • The amount of insulin and the best time for you to take your dose may need to change if you take different types of insulin or because of illness, increased stress, other medicines you take, change in diet, weight gain or loss, or change in physical activity or exercise.
  • Humalog U-200 must ONLY be injected with the single-patient-use Humalog U-200 KwikPen. The Humalog U-200 KwikPen contains 2 times as much insulin (200 units/mL) in 1 mL as standard insulin (100 units/mL). Do not withdraw Humalog U-200 from your KwikPen using a syringe. It could result in an overdose causing severe low blood sugar which may put your life in danger.

Who should not take Humalog U-100, Humalog U-200, Humalog Mix75/25, Humalog Mix50/50, or Insulin Lispro Injection?

  • Do not take these insulins if your blood sugar is too low (hypoglycemia) or if you are allergic to insulin lispro or any of the ingredients in these insulins.

What should I tell my healthcare provider before taking Humalog U-100, Humalog U-200, Humalog Mix75/25, Humalog Mix50/50 or Insulin Lispro Injection?

Tell your healthcare provider about all of your medical conditions and all of the medicines you take, including if you:

  • have heart failure or other heart, liver, or kidney problems.
  • are pregnant, breastfeeding, or plan to become pregnant or breastfeed.
  • take medicines commonly called TZDs (thiazolidinediones) or any other prescription or over-the-counter medicines, vitamins, and herbal supplements.

What are the possible side effects of Humalog U-100, Humalog U-200, Humalog Mix75/25, Humalog Mix50/50 and Insulin Lispro Injection?

  • Low blood sugar is the most common side effect. Severe low blood sugar may put your life in danger and can cause seizures or death. Signs and symptoms of low blood sugar may be different for each person and may include dizziness or light-headedness, sweating, confusion, headache, blurred vision, slurred speech, shakiness, fast heartbeat, anxiety, irritability or mood changes, and hunger. Your healthcare provider may prescribe a glucagon emergency kit if your blood sugar becomes too low and you are unable to take sugar by mouth. Be sure to talk to your healthcare provider about low blood sugar and how to manage it.
  • Severe life-threatening allergic reactions (whole-body reactions) can happen. Get medical help right away if you have: a rash over your whole body, trouble breathing, shortness of breath, a fast heartbeat, swelling of your face, tongue or throat, sweating, extreme drowsiness, dizziness, or confusion or feel faint.
  • Humalog U-100, Humalog U-200, Humalog Mix75/25, Humalog Mix50/50, and Insulin Lispro Injection can cause life-threatening low potassium in your blood (hypokalemia). This can cause severe breathing problems, irregular heartbeat, and death.
  • Swelling of your hands and feet and heart failure may occur when taking certain pills called thiazolidinediones or “TZDs” with Humalog U-100, Humalog U-200, Humalog Mix75/25, Humalog Mix50/50, or Insulin Lispro Injection. This can happen in some people even if they have not had heart problems before. Tell your healthcare provider if you have shortness of breath, swelling of your ankles or feet, or sudden weight gain, which may be symptoms of heart failure. Your healthcare provider may need to adjust or stop your treatment with TZDs and Humalog U-100, Humalog U-200, Humalog Mix75/25, Humalog Mix50/50, or Insulin Lispro Injection.
  • Failure of your insulin pump or infusion set or degradation of the insulin in the pump can cause hyperglycemia and ketoacidosis. Always carry an alternate form of insulin administration in case of pump failure.
  • The most common side effects of Humalog U-100, Humalog U-200, Humalog Mix75/25, Humalog Mix50/50, and Insulin Lispro Injection include: low blood sugar, allergic reactions, including reactions at your injection site, skin thickening or pits at the injection site (lipodystrophy), weight gain, swelling in your hands or feet, itching, and rash.

These are not all of the possible side effects. Ask your healthcare provider for more information or for medical advice about side effects. You are encouraged to report side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

How should I take Humalog U-100, Humalog U-200, Humalog Mix75/25, Humalog Mix50/50, or Insulin Lispro Injection?

  • Check your insulin label before each injection to make sure you are taking the correct type of insulin.
  • Do not re-use needles. Always use a new needle for each injection. Re-use of needles can cause you to get the wrong dose of insulin or result in a serious infection.
  • These insulins start acting fast. Inject Humalog U-100, Humalog U-200, or Insulin Lispro Injection within fifteen minutes before or right after eating a meal. Inject Humalog Mix75/25 or Humalog Mix50/50 within fifteen minutes before you eat a meal.
  • Inject your insulin under your skin (subcutaneously). Never inject into a vein or muscle.
  • Change (rotate) where you inject your insulin with each dose.  This can reduce your chance of getting pits, lumps, or thickened skin where you inject your insulin. Do not inject your insulin into the exact same spot or where the skin has pits or lumps. Avoid injecting into thickened, tender, bruised, scaly, hard, or damaged skin.   
  • Never mix Humalog U-200, Humalog Mix75/25, or Humalog Mix50/50 with other insulins or liquids. Never use Humalog U-200, Humalog Mix75/25, or Humalog Mix50/50 in a pump.
  • Do not drive or operate heavy machinery until you know how Humalog U-100, Humalog U-200, Humalog Mix75/25, Humalog Mix50/50, or Insulin Lispro Injection affects you.
  • Do not drink alcohol or take medicines that contain alcohol while taking Humalog U-100, Humalog U-200, Humalog Mix75/25, Humalog Mix50/50, or Insulin Lispro Injection.

Humalog U-100, Humalog U-200, Humalog Mix75/25, Humalog Mix50/50, and Insulin Lispro Injection are available by prescription only.

For additional information talk to your healthcare providers and please click to access Humalog Full Prescribing Information, Humalog U-100 Patient Prescribing Information, Humalog U-200 Patient Prescribing Information, Humalog Mix75/25 Full Prescribing Information, Humalog Mix75/25 Patient Prescribing Information, Humalog Mix50/50 Full Prescribing Information, Humalog Mix50/50 Patient Prescribing Information, Insulin Lispro Injection Full Prescribing Information, and Insulin Lispro Injection Patient Prescribing Information

Please see Humalog U-100 KwikPen Instructions for Use / Humalog Junior KwikPen Instructions for Use / Humalog U-100 Vial Instructions for Use / Humalog U-200 KwikPen Instructions for Use / Humalog Mix75/25 KwikPen Instructions for Use / Humalog Mix75/25 Vial Instructions for Use / Humalog Mix50/50 KwikPen Instructions for Use / Humalog Mix50/50 Vial Instructions for Use / Insulin Lispro Injection KwikPen Instructions for Use / Insulin Lispro Injection Vial Instructions for Use included with your pen.

HI BOI SP CON ISI 15NOV2019

VIEW ALL

Indication for Humalog Brand of Insulins and Insulin Lispro Injection

Humalog and Insulin Lispro Injection are indicated to improve glycemic control in adults and children with diabetes mellitus. Humalog Mix75/25 and Humalog Mix50/50 are indicated to improve glycemic control in patients with diabetes mellitus.

Limitations of Use for Humalog Mix75/25 and Humalog Mix50/50: The proportions of rapid-acting and intermediate acting insulins in Humalog Mix75/25 and Humalog Mix50/50 are fixed and do not allow for basal versus prandial dose adjustments.

Important Safety Information for Humalog Brand of Insulins and Insulin Lispro Injection

  • Contraindications


    Humalog, Insulin Lispro Injection, Humalog Mix75/25, and Humalog Mix50/50 are contraindicated during episodes of hypoglycemia and in patients who are hypersensitive to these insulins or any of their excipients.
  • Warnings and Precautions


    Never share a Humalog, Insulin Lispro Injection, Humalog Mix75/25, or Humalog Mix50/50 prefilled pen, cartridge, reusable pen compatible with Lilly 3 mL cartridges, or syringe between patients, even if the needle is changed. Patients using vials must never share needles or syringes with another person. Sharing poses a risk for transmission of blood-borne pathogens.

    Hyperglycemia or Hypoglycemia with Changes in Insulin Regimen: Changes in insulin strength, manufacturer, type, injection site, or method of administration may affect glycemic control and predispose to hypoglycemia or hyperglycemia. Any changes in insulin regimen should be made cautiously under close medical supervision and the frequency of blood glucose monitoring should be increased. Due to reports of hyperglycemia and hypoglycemia, advise patients who have repeatedly injected into areas of lipodystrophy or localized cutaneous amyloidosis to change the injection site to unaffected areas and closely monitor blood glucose. For patients with type 2 diabetes, dosage adjustments of concomitant antidiabetic products may be needed.

    Hypoglycemia: Severe hypoglycemia may be life threatening and can cause seizures or death. Hypoglycemia is the most common adverse reaction of Humalog, Insulin Lispro Injection, Humalog Mix75/25, and Humalog Mix50/50. Monitor blood glucose and increase monitoring frequency with changes to insulin dosage, use with glucose-lowering medications, meal pattern, physical activity; in patients with renal or hepatic impairment; and in patients with hypoglycemia unawareness.

    Hypoglycemia Due to Medication Errors: Instruct patients to always check the insulin label before each injection to avoid medication errors. Humalog U-200 should not be transferred from the Humalog KwikPen to a syringe as overdose and severe hypoglycemia can occur.

    Hypersensitivity Reactions: Severe, life-threatening, generalized allergy, including anaphylaxis, can occur with Humalog, Insulin Lispro Injection, Humalog Mix75/25, and Humalog Mix50/50. If hypersensitivity reactions occur, discontinue the use of insulin and treat per standard of care until signs and symptoms resolve.

    Hypokalemia: Hypokalemia may be life threatening. Insulins, including Humalog, Insulin Lispro Injection, Humalog Mix75/25, and Humalog Mix50/50, cause a shift in potassium from the extracellular to intracellular space possibly leading to hypokalemia, which, if untreated, may result in respiratory paralysis, ventricular arrhythmia, and death. Monitor potassium levels in patients at risk for hypokalemia (e.g., patients using potassium-lowering medications or medications sensitive to serum potassium concentrations).

    Fluid Retention and Heart Failure with Concomitant Use of PPAR-gamma Agonists: Thiazolidinediones (TZDs), which are PPAR-gamma agonists, can cause dose-related fluid retention, particularly when used in combination with insulin, including Humalog, Insulin Lispro Injection, Humalog Mix75/25, and Humalog Mix50/50. This may lead to or exacerbate heart failure. Observe patients for signs and symptoms of heart failure and consider discontinuation or dose reduction of the PPAR-gamma agonist.

    Hyperglycemia and Ketoacidosis Due to Insulin Pump Device Malfunction: Malfunction of the insulin pump device, infusion set, or insulin degradation can rapidly lead to hyperglycemia and ketoacidosis. Patients using subcutaneous insulin infusion pumps must be trained to administer insulin by injection and have alternate insulin therapy available in case of pump failure. 
  • Adverse Reactions


    Adverse reactions associated with Humalog, Insulin Lispro Injection, Humalog Mix75/25, and Humalog Mix50/50 include hypoglycemia, hypokalemia, allergic reactions, injection-site reactions, lipodystrophy, pruritus, rash, weight gain, and peripheral edema.
  • Drug Interactions


    Some medications may alter glucose metabolism, insulin requirements, and the risk for hypoglycemia or hyperglycemia. Signs of hypoglycemia may be reduced or absent in patients taking anti-adrenergic drugs. Particularly close monitoring may be required.

Please click to access Humalog Full Prescribing Information, Humalog Mix75/25 Full Prescribing Information, Humalog Mix50/50 Full Prescribing Information, and Insulin Lispro Injection Full Prescribing Information.

Please see Instructions for Use included with the pen.

HI BOI SP HCP ISI 15NOV2019

VIEW ALL

Indicación de la marca de insulinas Humalog

HUMALOG es un análogo de la insulina humana de acción rápida indicado para mejorar el control glucémico en adultos y niños con diabetes mellitus.

Información Importante de Seguridad

¿Cuál es la información más importante que debo conocer sobre Humalog U-100, Humalog U-200, Humalog Mix75/25, Humalog Mix50/50 y la inyección de insulina Lispro?

  • No comparta con otras personas su Humalog U-100, Humalog U-200, Humalog Mix75/25, Humalog Mix50/50, pluma precargada con la inyección de insulina Lispro, cartuchos, pluma reutilizable compatible con cartuchos Lilly de 3 mL, agujas o jeringas, incluso si la aguja ha sido cambiada. Puede transmitir a otras personas una infección grave o contraer una infección grave de ellos.
  • No cambie el tipo ni la cantidad de insulina que usted usa sin consultar a su proveedor de atención médica. Los cambios pueden aumentar o bajar el nivel de azúcar en la sangre. Los cambios deben realizarse cuidadosamente y con la supervisión de su proveedor de atención médica.
  • Verifique sus niveles de azúcar en la sangre según se lo indique su proveedor de atención médica.
  • Es posible que deba cambiar la cantidad de insulina y la mejor hora para tomar su dosis si toma diferentes tipos de insulina o debido a una enfermedad, aumento del estrés, otros medicamentos que toma, cambio en la dieta, aumento o pérdida de peso, o cambio en la actividad física o ejercicio.
  • Humalog U-200 SOLO debe inyectarse con la Humalog U-200 KwikPen. La Humalog U-200 KwikPen contiene 2 veces la cantidad de insulina (200 unidades/ml) en 1 mL que la insulina estándar (100 unidades/ml). No retire la Humalog U-200 de su KwikPen utilizando una jeringa. Podría resultar en una sobredosis y provocar niveles muy bajos de azúcar en la sangre, lo que puede poner su vida en peligro.

¿Quién no debe utilizar Humalog U-100, Humalog U-200, Humalog Mix75/25, Humalog Mix50/50 o la inyección de insulina Lispro?

  • No utilice estas insulinas si su nivel de azúcar en la sangre es demasiado bajo (hipoglucemia) o si usted es alérgico a la insulina lispro o a cualquiera de los ingredientes en estas insulinas.

¿Qué debo decirle a mi proveedor de atención médica antes de utilizar Humalog U-100, Humalog U-200, Humalog Mix75/25, Humalog Mix50/50 o la inyección de insulina Lispro?

Informe a su proveedor de atención médica sobre todas sus afecciones médicas y todos los medicamentos que toma, incluso si usted:

  • ha sufrido un ataque cardíaco o tiene otro problema cardíaco, hepático o renal.
  • está embarazada, amamantando o planea estar embarazada o amamantar.
  • toma medicamentos comúnmente llamados TZD (tiazolidinedionas) o cualquier otro medicamento recetado o de venta libre, vitaminas y suplementos a base de hierbas.

¿Cuáles son los posibles efectos secundarios de Humalog U-100, Humalog U-200, Humalog Mix75/25, Humalog Mix50/50 y la inyección de insulina Lispro?

  • El bajo nivel de azúcar en la sangre es el efecto secundario más común. Un nivel de azúcar en la sangre severamente bajo puede poner en peligro su vida y causar convulsiones o la muerte. Los signos y síntomas del nivel bajo de azúcar en la sangre pueden ser diferentes para cada persona y pueden incluir mareos o aturdimientos, sudoración, confusión, dolor de cabeza, visión borrosa, balbuceos, temblores, ritmo cardíaco acelerado, ansiedad, irritabilidad o cambios de humor, y apetito. Su proveedor de atención médica le puede recetar un kit de emergencia de glucagón si su nivel de azúcar en la sangre baja demasiado y usted no puede tomar azúcar por vía oral. Asegúrese de hablar con su proveedor de atención médica sobre la glucosa baja en la sangre y la forma de manejarla.
  • Pueden ocurrir reacciones alérgicas graves (reacciones en todo el cuerpo) que pueden poner en peligro su vida. Obtenga asistencia médica de inmediato si tiene: sarpullido en todo el cuerpo, dificultad para respirar, falta de aire, ritmo cardíaco acelerado, hinchazón de la cara, lengua o garganta, sudoración, somnolencia extrema, mareos o confusión.
  • Humalog U-100, Humalog U-200, Humalog Mix75/25, Humalog Mix50/50 y la inyección de insulina Lispro pueden causar niveles bajos de potasio en la sangre (hipocalemia) que pueden poner en peligro su vida. Esto puede causar problemas respiratorios graves, ritmo cardíaco irregular y la muerte.
  • Puede presentar hinchazón de manos y pies y sufrir insuficiencia cardíaca al utilizar ciertas píldoras llamadas tiazolidinedionas o “TZD” con Humalog U-100, Humalog U-200, Humalog Mix75/25, Humalog Mix50/50 o la inyección de insulina Lispro. Esto puede ocurrir incluso en personas que no hayan tenido problemas cardíacos anteriormente. Hable con su proveedor de atención médica si experimenta falta de aire, hinchazón de los tobillos o los pies, o un aumento repentino de peso, que podrían ser síntomas de insuficiencia cardíaca. Es posible que su proveedor de atención médica necesite ajustar o suspender su tratamiento con TZD y Humalog U-100, Humalog U-200, Humalog Mix75/25, Humalog Mix50/50 o la inyección de insulina Lispro.
  • La falla de la bomba de insulina o del equipo de infusión o la degradación de la insulina en la bomba pueden causar hiperglucemia y cetoacidosis. Siempre lleve consigo una forma alternativa de administrar insulina en caso de que la bomba falle.
  • Los efectos secundarios más comunes de Humalog U-100, Humalog U-200, Humalog Mix75/25, Humalog Mix50/50 y la inyección de insulina Lispro incluyen: bajo nivel de azúcar en la sangre, reacciones alérgicas, incluyendo reacciones en la zona de inyección, engrosamiento de la piel u hoyos en la zona de inyección (lipodistrofia), aumento de peso, hinchazón en las manos o los pies, picazón y sarpullido.

Estos no son todos los posibles efectos secundarios. Solicite a su proveedor de atención médica más información o consejos médicos sobre los efectos secundarios. Se le recomienda que informe cualquier efecto secundario de los medicamentos recetados a la FDA. Visite www.fda.gov/medwatch o llame al 1-800-FDA-1088.

¿Cómo debo utilizar Humalog U-100, Humalog U-200, Humalog Mix75/25, Humalog Mix50/50 o la inyección de insulina Lispro?

  • Verifique la etiqueta de su insulina antes de cada inyección para asegurarse de estar utilizando el tipo correcto de insulina.
  • No reutilice las agujas. Utilice siempre una nueva aguja para cada inyección. Reutilizar las agujas puede hacer que reciba la dosis incorrecta de insulina o puede provocar una infección grave.
  • Estas insulinas comienzan a actuar rápido. Inyéctese Humalog U-100, Humalog U-200 o la insulina Lispro dentro de quince minutos antes o justo después de comer. Inyéctese Humalog Mix75/25 o Humalog Mix50/50 dentro de quince minutos antes de comer.
  • Inyéctese su insulina debajo de la piel (subcutáneamente). Nunca se inyecte en una vena o en un músculo. Cambie (alterne) el lugar de la inyección en cada dosis.
  • Nunca mezcle Humalog U-200, Humalog Mix75/25 o Humalog Mix50/50 con otras insulinas o líquidos. Nunca utilice Humalog U-200, Humalog Mix75/25 o Humalog Mix50/50 en una bomba.
  • No conduzca ni opere maquinaria pesada hasta que sepa cómo le afecta Humalog U-100, Humalog U-200, Humalog Mix75/25, Humalog Mix50/50 o la inyección de insulina Lispro.
  • No beba alcohol ni tome medicamentos que contengan alcohol mientras utiliza Humalog U-100, Humalog U-200, Humalog Mix75/25, Humalog Mix50/50 o la inyección de insulina Lispro.

Humalog U-100, Humalog U-200, Humalog Mix75/25, Humalog Mix50/50 y la inyección de insulina Lispro están disponibles solo con receta médica.

Para obtener información adicional, hable con su proveedor de atención médica y sírvase hacer clic para acceder proporcionada información completa para recetar Humalog, información para recetar Humalog U-100 para el paciente, información para recetar Humalog U-200 para el paciente, información completa para recetar Humalog Mix75/25, información para recetar Humalog Mix75/25 para el paciente, información completa para recetar Humalog Mix50/50, información para recetar Humalog Mix50/50 para el paciente, información completa para recetar la inyección de insulina Lispro [e] información para recetar la inyección de insulina Lispro para el paciente.

Sírvase hacer clic para acceder proporcionada instrucciones de uso de KwikPen para Humalog U-100 / instrucciones de uso de Humalog Junior KwikPen / instrucciones de uso del vial de Humalog U-100 / instrucciones de uso de KwikPen para Humalog U-200 / instrucciones de uso de KwikPen para Humalog Mix75/25 / instrucciones de uso del vial de Humalog Mix75/25 / instrucciones de uso de KwikPen para Humalog Mix50/50 / instrucciones de uso del vial de Humalog Mix50/50 / instrucciones de uso de KwikPen para la inyección de insulina Lispro / instrucciones de uso del vial de inyección de insulina Lispro incluida con su pluma.

HI BOI SP CON ISI 13AUG2019

VIEW ALL

About Fast-Acting Mealtime Insulin

What is mealtime insulin?

Mealtime insulins are fast-acting insulins that are taken immediately before or after meals. As you eat, your blood sugar naturally goes up, or “spikes.” Humalog® (a fast-acting insulin) works to manage those blood sugar spikes and may help keep your sugar levels in balance. Humalog should be taken within 15 minutes before eating or right after eating a meal. People who take Humalog will usually continue to take longer-acting insulin to help manage blood sugar levels at night and between meals. Taking mealtime insulin in addition to longer-acting insulin may help to control blood sugar levels throughout the day.

Low blood sugar (hypoglycemia) is a possible side effect of insulin that may be severe and cause seizures or death. Signs and symptoms of low blood sugar may include dizziness or light-headedness, sweating, confusion, headache, blurred vision, slurred speech, shakiness, fast heartbeat, anxiety, irritability, mood changes, or hunger.

A chart that compares how blood sugar levels rise after meals.

The orange area shows how blood sugar levels typically rise after meals. The pattern of insulin action may vary in different individuals or within the same individual.

Humalog

Blood sugar

Longer-acting insulin

Comparing types of insulin

Take a look at our overview below to find out about the different types of insulin. You’ll notice that there are differences in when the types of insulin reach your bloodstream, when they “peak” in your body, and how long they can last (length of time the insulin keeps lowering your blood sugar).

  • Fast-acting insulin (also called rapid-acting) is absorbed quickly and starts working in about 15 minutes to lower blood sugar after meals. Humalog fast-acting insulin should be taken 15 minutes before eating or right after eating a meal.
  • Depending on the type of diabetes you have, you may need to take Humalog with a longer-acting insulin or oral anti-diabetes medication.
  • In people with type 1 diabetes, Humalog needs to be used with a longer-acting insulin (except when using an external insulin pump). When used in a pump, do not mix Humalog with any other insulin or liquid.
  • Humalog U-200 is a concentrated fast-acting insulin that is twice the concentration of Humalog U-100.
  • Short-acting insulin can cover insulin needs for meals eaten within 30 minutes after injection. Short-acting insulin is also considered a mealtime insulin.
  • Intermediate-acting insulin can cover your insulin needs between meals and during the night. It generally takes about 2-4 hours for this insulin to start working after injection.
  • Longer-acting or basal insulin manages blood sugar levels at night and between meals. Humalog works together with longer-acting insulin to help control your blood sugar throughout the day.

Humalog® Mix75/25 and Humalog® Mix50/50 contain both fast-acting and longer-acting insulin.

The times shown in our table and graph are estimates. Always work with your doctor to see what type of insulin is right for you. You can also see when and how often you should check your blood sugar levels.

Types of Insulin

 

Starts
Peaks
Lasts

Fast-acting

5-15 min
1-3 hr
4-6 hr

Short-acting

30-60 min
2-3 hr
6-10 hr

Intermediate-acting

2-4 hr
4-10 hr
14-18 hr

Longer-acting basal

1 hr approximately
Peakless
24 hr

The Lilly Answers Center

Talk with your doctor or call if you have questions. We’re here to help. Call
1-800-LillyRx (1-800-545-5979), Monday through Friday from 9 AM to 8 PM ET.

You clicked on a page that’s meant for healthcare providers.

This section includes technical information. If you’re a US healthcare provider, click “Continue.” Otherwise, click “Return” to keep reading the main site.

You are now leaving the Humalog.com website

The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Lilly USA, LLC, does not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Lilly USA, LLC. Lilly USA, LLC, is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.

Click "Continue" to proceed or "Cancel" to return to Humalog.com